RIGI and cancer: To investigate the underlying mechanism through which RIG-I regulates the biological characteristics of melanoma cells, we analyzed the effects of RIG-I on the modulation of the ERK, AKT and p38 MAPK pathways, which have been demonstrated to be critical regulators in the proliferation and apoptosis of cancer cells.